These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2329563
1. Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones. Zask A, Jirkovsky I, Nowicki JW, McCaleb ML. J Med Chem; 1990 May; 33(5):1418-23. PubMed ID: 2329563 [Abstract] [Full Text] [Related]
3. Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships. Arakawa K, Inamasu M, Matsumoto M, Okumura K, Yasuda K, Akatsuka H, Kawanami S, Watanabe A, Homma K, Saiga Y, Ozeki M, Iijima I. Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1984-93. PubMed ID: 9433768 [Abstract] [Full Text] [Related]
4. Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells. Arakawa K, Ishihara T, Aoto M, Inamasu M, Saito A, Ikezawa K. Br J Pharmacol; 1998 Oct; 125(3):429-36. PubMed ID: 9806323 [Abstract] [Full Text] [Related]
5. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone). Sohda T, Meguro K, Kawamatsu Y. Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2267-78. PubMed ID: 6488400 [No Abstract] [Full Text] [Related]
6. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents. Wrobel J, Dietrich A, Woolson SA, Millen J, McCaleb M, Harrison MC, Hohman TC, Sredy J, Sullivan D. J Med Chem; 1992 Nov 27; 35(24):4613-27. PubMed ID: 1469692 [Abstract] [Full Text] [Related]
7. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone. Tanis SP, Parker TT, Colca JR, Fisher RM, Kletzein RF. J Med Chem; 1996 Dec 20; 39(26):5053-63. PubMed ID: 8978836 [Abstract] [Full Text] [Related]
8. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones. Malamas MS, Sredy J, McCaleb M, Gunawan I, Mihan B, Sullivan D. Eur J Med Chem; 2001 Jan 20; 36(1):31-42. PubMed ID: 11231047 [Abstract] [Full Text] [Related]
19. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H. Diabetes; 1988 Nov 10; 37(11):1549-58. PubMed ID: 3053303 [Abstract] [Full Text] [Related]
20. Novel thiazolidine-2,4-diones as potent euglycemic agents. Hulin B, Clark DA, Goldstein SW, McDermott RE, Dambek PJ, Kappeler WH, Lamphere CH, Lewis DM, Rizzi JP. J Med Chem; 1992 May 15; 35(10):1853-64. PubMed ID: 1588563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]